Omega‐3 fatty acids protect from colitis via an Alox15‐derived eicosanoid
Open Access
- 12 March 2021
- journal article
- research article
- Published by Wiley in The FASEB Journal
- Vol. 35 (4) , e21491
Abstract
An increased omega‐3 polyunsaturated fatty acid (n‐3 PUFA) tissue status can lead to a significant formation of anti‐inflammatory lipid mediators and effective reduction in inflammation and tissue injury in murine colitis. Arachidonic acid lipoxygenases (ALOX) have been implicated in the pathogenesis of inflammatory bowel disease as well as in the formation of pro‐ and anti‐inflammatory lipid mediators. To explore the role of Alox15 in the protective response found in fat1 transgenic mice with endogenously increased n‐3 PUFA tissue status fat1 transgenic mice were crossed with Alox15 ‐deficient animals and challenged in the dextran sulfate sodium (DSS)‐ and the 2,4,6‐trinitrobenzene sulphonic acid (TNBS)‐induced colitis model. Transgenic fat1 mice rich in endogenous n‐3 PUFAs were protected from colitis. However, additional systemic inactivation of the Alox15 gene counteracted this protective effect. To explore the molecular basis for this effect Alox15 lipid metabolites derived from n‐3 PUFA were analyzed in the different mice. Alox15 deficiency suppressed the formation of n‐3 PUFA‐derived 15‐hydroxy eicosapentaenoic acid (15‐HEPE). In contrast, treating mice with intraperitoneal injections of 15S‐HEPE protected wild‐type mice from DSS‐ and TNBS‐induced colitis. These data suggest that the anti‐colitis effect of increased n‐3 PUFA in the transgenic fat1 mouse model is mediated in part via Alox15‐derived 15‐HEPE formation.Keywords
Funding Information
- Deutsche Forschungsgemeinschaft (KU961/11‐1)
- Deutsche Forschungsgemeinschaft (KU961/13‐1)
- Deutsche Forschungsgemeinschaft (WE2908/11‐1)
This publication has 45 references indexed in Scilit:
- Resolvins and Protectins in Inflammation ResolutionChemical Reviews, 2011
- Mechanisms for anti‐inflammatory effects of 1‐[15(S)‐hydroxyeicosapentaenoyl] lysophosphatidylcholine, administered intraperitoneally, in zymosan A‐induced peritonitisBritish Journal of Pharmacology, 2010
- Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxificationProceedings of the National Academy of Sciences, 2010
- Resolvin E1, an endogenous lipid mediator derived from eicosapentaenoic acid, prevents dextran sulfate sodium–induced colitisInflammatory Bowel Diseases, 2010
- ERK-mediated regulation of leukotriene biosynthesis by androgens: A molecular basis for gender differences in inflammation and asthmaProceedings of the National Academy of Sciences, 2008
- Fat-1 transgenic mice: A new model for omega-3 researchProstaglandins, Leukotrienes and Essential Fatty Acids, 2007
- Unravelling the pathogenesis of inflammatory bowel diseaseNature, 2007
- Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitisProceedings of the National Academy of Sciences, 2006
- 5-LIPOXYGENASE MODULATES THE ALTERATION OF PARACELLULAR BARRIER FUNCTION IN MICE ILEUM DURING EXPERIMENTAL COLITISShock, 2006
- Cloning and characterization of a murine macrophage lipoxygenaseBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995